August 13 2018 - Racing Novartis on Eylea rival, FDA trips Regeneron at the finish line

Racing Novartis on Eylea rival, FDA trips Regeneron at the finish line
Sarepta invest $30 million in gene therapy company
PhRMA says R&D spending hit record in 2017
Vertex Pharma’s fight club rule
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

Our microbiome database currently has 73 conditions for which biome-based products are being developed, & more added regularly. Review products by company, conditions treated, stage of development. Free access w/a subscription to our premium newsletter.

Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com